A Prospective Study Evaluating the Safety and Effectiveness of EVARREST® Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (Non-cardiac) Surgery in Pediatric Patients
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2018
At a glance
- Drugs Fibrin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors Ethicon
- 25 Jan 2018 Planned initiation date changed from 31 Oct 2017 to 28 Feb 2018.
- 25 Jan 2018 Planned End Date changed from 31 Jan 2020 to 28 Feb 2018.
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.